On Tuesday, Shares of Banco Bilbao Vizcaya Argentaria (NYSE:BBVA), lost -1.06% to $8.42.
BBVA Compass declared recently that its Chairman and CEO Manolo Sánchez has been elected to the American Bankers Association’s board of directors, joining CEOs from banks of all sizes on the ABA’s governing body.
Sánchez will serve a three-year term on the board, where he will represent the interests of the U.S. banking industry, BBVA Compass and the communities in the bank’s Sunbelt region. ABA, which serves as a united voice for the nation’s $16 trillion banking industry and its more than 2 million employees, provides educational benefits and programs for its members, represents the banking industry in Washington and speaks on behalf of it in the press.
“I’m honored to have this opportunity to serve on ABA’s board as it works to address some of the core issues the financial industry is facing,” Sánchez said. “We are part of an industry that will see immense change in the coming years — change on a scale similar to the revolutions that forever altered the music, media, retail and technology industries.”
Banco Bilbao Vizcaya Argentaria, S.A. engages in the retail banking, wholesale banking, asset administration, and private banking businesses primarily in Spain, Eurasia, Mexico, South America, and the United States.
Shares of CMS Energy Corporation (NYSE:CMS), inclined 1.72% to $34.99, during its last trading session.
With stormy weather predicted later this week, Consumers Energy is introducing automatic outage alerts for its 1.8 million residential and business electric customers to provide them with accurate, up-to-date information during a power outage.
The outage alerts let customers know their power is out and the estimated restoration time. Customers can reply to the alert to provide an update on their situation or request updated information.
“Providing our customers with timely information during power outages can assist them stay safe, make decisions and remain informed,” said Garrick Rochow, Consumers Energy vice president and chief customer officer. “Keeping our customers and our communities safe is part of our Promise to Michigan.”
CMS Energy Corporation operates as an energy company primarily in Michigan, the United States. The company’s Electric Utility segment engages in the generation, purchase, distribution, and sale of electricity to residential, commercial, and various industrial customers in Michigan’s Lower Peninsula.
Finally, Shares of Eli Lilly and Co (NYSE:LLY), ended its last trade with 1.52% gain, and closed at $80.06.
WuXi PharmaTech and Eli Lilly and Company, declared that they have reached a planned partnership to develop, manufacture and commercialize a novel small molecule in China.
The potential medicine is a novel, once-daily oral agent, discovered by Lilly, which could address cardiovascular risk in patients with dyslipidemia, representing an unmet medical need worldwide. An estimated 276 million patients in China are affected by these conditions, counting about 12 million patients requiring drug treatment. The potential medicine aims to reduce cardiovascular events in patients with elevated LDL cholesterol and triglycerides at high risk of cardiovascular events.
WuXi will be responsible for regulatory, development and manufacturing activities in China, which will be led and coordinated by WuXi’s Product Development Service and Partnership (PDSP) Business Unit. The potential medicine will be manufactured in China by WuXi to support China development. Lilly will be responsible for commercial activities. The parties will both invest in bringing this potential new medicine to patients in China. Further financial terms of the partnership were not revealed. An Investigational New Drug (IND) application will be filed in China by WuXi, and product development and registration will be carried out within China.
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency.